• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者视觉功能障碍的管理。

Management of Visual Dysfunction in Patients with Parkinson's Disease.

机构信息

Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.

Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Neuro-Ophthalmology, Baltimore, MD, USA.

出版信息

J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.

DOI:10.3233/JPD-202103
PMID:32741840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7592686/
Abstract

Parkinson's disease (PD) is a movement disorder with many symptoms responsive to treatment with dopamine agonists, anti-cholinergics and the dopamine precursor, levodopa. The cardinal features of PD include tremor, rigidity, bradykinesia, and postural instability. There also are non-motor features that include sleep disorders, cognitive and affective dysfunction, hyposmia, pain and dysautonomia (constipation, bloating, orthostasis, urinary symptoms, sexual dysfunction, dysphagia). Among these non-motor features are signs and symptoms of visual system impairment that range from subtle examination findings to those causing severe disability. In this review we describe common PD-related abnormalities in the visual system, how they present, and potential treatments.

摘要

帕金森病(PD)是一种运动障碍疾病,许多症状对多巴胺激动剂、抗胆碱能药物和多巴胺前体左旋多巴的治疗有反应。PD 的主要特征包括震颤、僵硬、运动迟缓以及姿势不稳。还有一些非运动特征,包括睡眠障碍、认知和情感功能障碍、嗅觉减退、疼痛和自主神经功能障碍(便秘、腹胀、直立性低血压、尿症状、性功能障碍、吞咽困难)。这些非运动特征包括从细微的检查结果到导致严重残疾的视觉系统损伤的迹象和症状。在这篇综述中,我们描述了常见的与 PD 相关的视觉系统异常,以及它们的表现和潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d591/7592686/2b967da924d1/jpd-10-jpd202103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d591/7592686/2b967da924d1/jpd-10-jpd202103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d591/7592686/2b967da924d1/jpd-10-jpd202103-g001.jpg

相似文献

1
Management of Visual Dysfunction in Patients with Parkinson's Disease.帕金森病患者视觉功能障碍的管理。
J Parkinsons Dis. 2020;10(s1):S49-S56. doi: 10.3233/JPD-202103.
2
Visual dysfunction in Parkinson's disease.帕金森病中的视觉功能障碍。
Clin Neurosci. 1998;5(2):102-6.
3
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗:综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
4
Oculo-Visual Dysfunction in Parkinson's Disease.帕金森病中的眼视觉功能障碍
J Parkinsons Dis. 2015;5(4):715-26. doi: 10.3233/JPD-150686.
5
Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.帕金森病的眼视觉异常:作为生物标志物的可能价值。
Mov Disord. 2018 Sep;33(9):1390-1406. doi: 10.1002/mds.27454.
6
Testing an aetiological model of visual hallucinations in Parkinson's disease.测试帕金森病视觉幻觉的病因学模型。
Brain. 2011 Nov;134(Pt 11):3299-309. doi: 10.1093/brain/awr225. Epub 2011 Sep 15.
7
Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study.帕金森病患者低体重指数的决定因素:一项多中心病例对照研究。
J Parkinsons Dis. 2020;10(1):213-221. doi: 10.3233/JPD-191741.
8
Non-motor features of Parkinson's disease: depression and dementia.帕金森病的非运动症状:抑郁和痴呆。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S87-92. doi: 10.1016/S1353-8020(09)70789-8.
9
Visual Dysfunction in Parkinson's Disease.帕金森病中的视觉功能障碍
Int Rev Neurobiol. 2017;134:921-946. doi: 10.1016/bs.irn.2017.04.007. Epub 2017 May 31.
10
Multifactorial sleep disturbance in Parkinson's disease.帕金森病中的多因素睡眠障碍
Sleep Med. 2017 Jul;35:41-48. doi: 10.1016/j.sleep.2017.03.026. Epub 2017 Apr 25.

引用本文的文献

1
Unraveling the role of neuregulin-mediated astrocytes-OPCs axis in the pathogenesis of age-related macular degeneration and Parkinson's disease.解析神经调节蛋白介导的星形胶质细胞-少突胶质前体细胞轴在年龄相关性黄斑变性和帕金森病发病机制中的作用。
Sci Rep. 2025 Mar 1;15(1):7352. doi: 10.1038/s41598-025-92103-8.
2
The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?将技术融入基于家庭的视认知训练干预中,用于帕金森病患者:未来是数字化的吗?
PLoS One. 2023 Jun 15;18(6):e0285100. doi: 10.1371/journal.pone.0285100. eCollection 2023.
3
Narrative Review Concerning the Clinical Spectrum of Ophthalmological Impairments in Parkinson's Disease.

本文引用的文献

1
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.神经和眼科疾病中的视幻觉:病理生理学与治疗。
J Neurol Neurosurg Psychiatry. 2020 May;91(5):512-519. doi: 10.1136/jnnp-2019-322702. Epub 2020 Mar 25.
2
Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire.帕金森病中的眼科问题:视力障碍问卷的结果。
Neurology. 2020 Apr 7;94(14):e1539-e1547. doi: 10.1212/WNL.0000000000009214. Epub 2020 Mar 11.
3
Rapid picture naming in Parkinson's disease using the Mobile Universal Lexicon Evaluation System (MULES).
关于帕金森病眼部损害临床谱的叙述性综述
Neurol Int. 2023 Jan 26;15(1):140-161. doi: 10.3390/neurolint15010012.
4
Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.探索视认知技术训练在帕金森病中的可行性:一项先导随机对照试验研究方案。
PLoS One. 2022 Oct 7;17(10):e0275738. doi: 10.1371/journal.pone.0275738. eCollection 2022.
5
Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.肉毒杆菌神经毒素治疗帕金森病自主症状的应用:最新综述。
Toxins (Basel). 2021 Mar 19;13(3):226. doi: 10.3390/toxins13030226.
6
Approach to Cognitive Impairment in Parkinson's Disease.帕金森病认知障碍的处理方法。
Neurotherapeutics. 2020 Oct;17(4):1495-1510. doi: 10.1007/s13311-020-00963-x. Epub 2020 Nov 17.
使用移动通用词汇评估系统(MULES)对帕金森病患者进行快速图片命名。
J Neurol Sci. 2020 Mar 15;410:116680. doi: 10.1016/j.jns.2020.116680. Epub 2020 Jan 9.
4
The Pharmacology of Visual Hallucinations in Synucleinopathies.突触核蛋白病中视幻觉的药理学
Front Pharmacol. 2019 Dec 9;10:1379. doi: 10.3389/fphar.2019.01379. eCollection 2019.
5
Visual Hallucinations and Impaired Conscious Visual Perception in Parkinson Disease.帕金森病的视幻觉和意识性视觉知觉障碍。
J Geriatr Psychiatry Neurol. 2020 Nov;33(6):377-385. doi: 10.1177/0891988719892318. Epub 2019 Dec 6.
6
Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe.帕金森病患者的自我报告视觉功能障碍:欧洲健康、老龄化和退休调查。
Eur J Neurol. 2020 Mar;27(3):484-489. doi: 10.1111/ene.14092. Epub 2019 Oct 19.
7
Atypical antipsychotics for Parkinson's disease psychosis: a systematic review and meta-analysis.用于帕金森病精神病的非典型抗精神病药物:系统评价与荟萃分析。
Neuropsychiatr Dis Treat. 2019 Jul 29;15:2137-2149. doi: 10.2147/NDT.S201029. eCollection 2019.
8
The role of Optical Coherence Tomography in Parkinsonism: A critical review.光学相干断层扫描在帕金森病中的作用:批判性评价。
J Neurol Sci. 2019 Aug 15;403:67-74. doi: 10.1016/j.jns.2019.06.009. Epub 2019 Jun 12.
9
Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.帕金森病的视网膜层:频域光学相干断层扫描研究的荟萃分析。
Parkinsonism Relat Disord. 2019 Jul;64:40-49. doi: 10.1016/j.parkreldis.2019.04.023. Epub 2019 Apr 30.
10
Corneal Evaluation in Patients With Parkinsonism on Long-Term Amantadine Therapy.长期接受金刚烷胺治疗的帕金森病患者的角膜评估
Cornea. 2019 Sep;38(9):1131-1136. doi: 10.1097/ICO.0000000000001951.